GLOBAL INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

GLOBAL INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

  • June 2021 •
  • 245 pages •
  • Report ID: 5304126 •
  • Format: PDF
KEY FINDINGS
The global infertility testing & treatment market is projected to register a CAGR of 10.63% over the forecasting period of 2021 to 2028. The market growth is facilitated by key factors such as, rising stress and lifestyle disorders, increased age of conception, the surging government support, and elevating effectiveness of treatment.

MARKET INSIGHTS
Infertility is characterized as the inability to get pregnant, despite engaging in carefully timed and unprotected intercourse for 12 months.Although the cause of infertility is often difficult to determine, it may include insufficient levels of specific hormones in both women and men, in addition to problems with ovulation in women.

Infertility tests typically include several special procedures, semen analysis, physical exams, and blood tests.
Aging significantly affects fertility.A woman’s ability to conceive begins to reduce after the age of 35.

Furthermore, male fertility begins to decrease around the age of 40 to 45, with the reduction of sperm quality.Hence the demand for infertility testing and treatment solutions is continually rising.

Age-related infertility is often perceived as an issue that can be easily resolved by assisted conception. As a result, the demand for infertility drugs rises as the rates of late pregnancies surge.

REGIONAL INSIGHTS
The global infertility testing & treatment market growth assessment includes an in-depth analysis of the Asia-Pacific, Europe, North America, and the Rest of World.The Asia-Pacific is set to grow with the highest CAGR over the forecast period, primarily owing to the rise in fertility tourism and the surging adoption of fertility procedures.

Besides, relatively cheaper treatments in countries such as Singapore, Malaysia, Thailand, South Korea, and India further augment the regional market’s growth.

COMPETITIVE INSIGHTS
The industry rivalry is expected to be high in the market on account of the availability of multiple infertility testing & treatment market players.Moreover, the increasing rate of infertility rate as well as healthcare expenditures attracts potential investors to invest in the global market, thereby reinforcing the competition.

Some of the key companies operating in the market are CooperSurgical, EMD Group (Merck KGaA), Fujifilm Irvine Scientific, Cook Medical Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ADORFEM
2. BANGKOK IVF CENTER
3. COOK MEDICAL INC
4. COOPER SURGICAL
5. CREATE FERTILITY CENTRE
6. EMD GROUP (MERCK KGAA)
7. ENDO INTERNATIONAL PLC
8. ESCO MEDICAL
9. FERRING PHARMACEUTICALS
10. FERTILITY FIRST
11. FUJIFILM IRVINE SCIENTIFIC
12. GENEA LTD
13. HALOTECH DNA
14. HAMILTON THRONE LTD
15. IVFTECH
16. LABOTECT GMBH
17. OLYMPUS CORPORATION
18. PROGYNY
19. THERMO FISHER SCIENTIFIC INC
20. VITROLIFE AB